Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_provenance.
- NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_assertion description "[Fourier transform infrared (FTIR) spectroscopy was used to study the structure of the recombinant antibodies 1E10, anti-CD20 and hR3, which are used as anti-cancer therapeutic drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_provenance.
- NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_assertion evidence source_evidence_literature NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_provenance.
- NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_assertion SIO_000772 23290364 NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_provenance.
- NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_assertion wasDerivedFrom befree-20150227 NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_provenance.
- NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_assertion wasGeneratedBy ECO_0000203 NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP291151.RAaFORxD10v2dsP5GJBcvgUbVhXmpyjCYNJ7pJ_xVG-lE130_provenance.